Burley, United Kingdom

Gareth Thomas

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Calliditas Therapeutics Suisse Sa, University of Southampton. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gareth Thomas. Retrieved from https://idiyas.com/inventor/gareth-thomas-gxmu089k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gareth Thomas: Innovator in Cancer Treatment

Introduction

Gareth Thomas is a notable inventor based in Burley, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the effectiveness of immunotherapy, particularly in restoring responsiveness to various cancer treatments.

Latest Patents

Gareth Thomas holds a patent for the "Use of NOX inhibitors for treatment of cancer." This invention relates to compounds, methods, compositions, and uses that can restore responsiveness to immunotherapy, specifically immune checkpoint inhibitors, anti-cancer vaccines, or anti-angiogenesis treatments. His patent represents a crucial advancement in the ongoing battle against cancer.

Career Highlights

Throughout his career, Gareth has worked with prominent organizations, including Calliditas Therapeutics Suisse SA and the University of Southampton. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Gareth has collaborated with notable colleagues such as Christopher Hanley and Kirsty Ford. These partnerships have further enriched his research and development efforts in cancer treatment.

Conclusion

Gareth Thomas is a dedicated inventor whose work in cancer treatment through NOX inhibitors showcases his commitment to improving patient outcomes. His contributions to the field are invaluable and highlight the importance of innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…